Christopher Banfield
Pfizer (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Asthma and respiratory diseases, Pharmacological Effects and Toxicity Studies, Dermatology and Skin Diseases, Epilepsy research and treatment
Most-Cited Works
- → Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans(2008)507 cited
- → A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee(2011)241 cited
- → Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint(2001)240 cited
- → Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study(2004)196 cited
- → A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results(2021)185 cited
- → Phenylbutazone‐warfarin interaction in man: further stereochemical and metabolic considerations.(1983)109 cited